Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 729455Generated: October 30, 2026

Triethylamine → tert-butyl (5-{5-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]pyrazin-2-yl}-2H-tetrazol-2-yl)acetate

https://huagongshe.com/reaction/729455

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamineHCID 8471—
Reactanttert-Butyl bromoacetateHCID 79177—
ReactantHCID 57832734HCID 57832734—
SolventTetrahydrofuranHCID 8028—
Producttert-butyl (5-{5-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]pyrazin-2-yl}-2H-tetrazol-2-yl)acetateHCID 86621799—

Reaction Steps

To a mixture of 2-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-5-(2H-tetrazol-5-yl)pyrazine from Step 6 (5.00 g, 11.9 mmol) and triethylamine (3.32 mL, 23.8 mmol) in THF (50 mL) at 60° C. was added tert-butyl bromoacetate (3.48 g, 17.9 mmol). After a period of 1 h at 60° C., the reaction mixture was partitioned between ethyl acetate and saturated ammonium chloride. The organic phase was separated, dried over sodium sulfate, filtered and evaporated. To the solid was added 50 mL of acetone followed by slow addition of 100 mL of hexane. The resulting solid was filtered to provide tert-butyl (5-{5-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]pyrazin-2-yl}-2H-tetrazol-2-yl)acetate.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07582633B2
Source datasetuspto-grants-2009_09
ORD IDord-9412a985543a4603a570e372dbcb6613
Source noteuspto-grants-2009_09